Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Why We Continue To Like This Company. More details...
Loses Patent Protection Suit to Teva. More details...
Biotech Can't Keep Winning Streak Alive. More details...
First Time It Prohibts FDA Approved Drug. More details...
Broad Market Closes Mixed. More details...
But Says Celebrex Causes Cardiovascular Problems. More...
Biotech Scores Small Gain. More details...
CBT 200 Books 1% Loss. More details...
Will the Brouhaha Produce Major Changes?. More details...
Biotech Postpones Another IPO. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
